Janeen Noel Doyle Janux Therapeutics, Inc. (JANX) insider trading activity
Janeen Noel Doyle is Chief Corp. & Bus. Dev. Ofcr of Janux Therapeutics, Inc.. Currently has a direct ownership of 44,000 shares of JANX, which is worth approximately $1.22 Million. The most recent transaction as insider was on Jun 02, 2025, when has been sold 44,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
44K
n/a
3M change
n/a
12M change
Total Value Held
$1.22 Million
JND
Janeen Noel Doyle
Chief Corp. & Bus. Dev. Ofcr
San Diego, CA